Pilar Requena, Gloria Patricia Gómez-Pérez, Matthew B B McCall, Diana Barrios, Ruth Aguilar, Julia Fernández-Morata, Marta Vidal, Joseph J Campo, Carla Sanchez, Maria Yazdabankhsh, B Kim Lee Sim, Stephen L Hoffman, Peter Kremsner, Bertrand Lell, Benjamin Mordmüller, Carlota Dobaño, Gemma Moncunill
{"title":"人恶性疟原虫感染控制对不同疟疾免疫水平个体B细胞亚群的影响","authors":"Pilar Requena, Gloria Patricia Gómez-Pérez, Matthew B B McCall, Diana Barrios, Ruth Aguilar, Julia Fernández-Morata, Marta Vidal, Joseph J Campo, Carla Sanchez, Maria Yazdabankhsh, B Kim Lee Sim, Stephen L Hoffman, Peter Kremsner, Bertrand Lell, Benjamin Mordmüller, Carlota Dobaño, Gemma Moncunill","doi":"10.1007/s00430-025-00847-x","DOIUrl":null,"url":null,"abstract":"<p><p>Continuous exposure to Plasmodium falciparum (Pf) has been associated with alterations in B cells. We investigated the effect of controlled human malaria infection (CHMI) on B cell phenotypes in individuals with different Pf immunity status: malaria-naïve, immunized with PfSPZ-CVac and semi-immune (lifelong-exposed) volunteers. Compared to naïve, semi-immune but not vaccinated individuals, had increased baseline frequencies of immature B cells (CD19<sup>+</sup>CD10<sup>+</sup>), active naive (IgD<sup>+</sup>CD27<sup>-</sup>CD21<sup>-</sup>) B cells, active atypical (IgD<sup>-</sup>CD27<sup>-</sup>CD21<sup>-</sup>) memory B cells (MBCs), active classical (IgD<sup>-</sup>CD27<sup>+</sup>CD21<sup>-</sup>) MBCs and CD1c<sup>+</sup>-B cells but lower frequencies of some IgG<sup>+</sup>-B cells. The frequencies of CD1c<sup>+</sup> active atypical MBCs correlated positively with anti-Pf antibodies and negatively with circulating eotaxin levels, while the opposite was observed for IgG<sup>+</sup> resting atypical MBCs. During early blood-stage infection (day 11 after CHMI), there was an expansion of resting classical (IgD<sup>-</sup>CD27<sup>+</sup>CD21<sup>+</sup>) MBCs in all three groups. Vaccination, compared to placebo, altered the effect of CHMI on B cells, showing a positive association with resting classical MBCs (β = 0.190, 95% CI 0.011-0.368) and active naïve-PD1<sup>+</sup> (β = 0.637, 95% CI 0.058 to 1.217) frequencies, and a negative one with CD1c<sup>+</sup> resting atypical MBCs (β = - 0.328, 95% CI - 0.621 to - 0.032). In addition, the sickle cell trait in semi-immune subjects altered the effect of CHMI on several B cells. In conclusion, lifelong but not vaccine exposure to malaria was associated with increased frequencies of multiple B cell subsets, with higher and lower percentages of CD1c and IgG expressing-cells, respectively. A single infection (CHMI) induces changes in B cell frequencies and is modulated by sickle cell trait and malaria-immunity status.Clinical Trials Registration NCT01624961, NCT02115516, and NCT02237586.</p>","PeriodicalId":18369,"journal":{"name":"Medical Microbiology and Immunology","volume":"214 1","pages":"47"},"PeriodicalIF":3.0000,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476306/pdf/","citationCount":"0","resultStr":"{\"title\":\"Effect of controlled human Plasmodium falciparum infection on B cell subsets in individuals with different levels of malaria immunity.\",\"authors\":\"Pilar Requena, Gloria Patricia Gómez-Pérez, Matthew B B McCall, Diana Barrios, Ruth Aguilar, Julia Fernández-Morata, Marta Vidal, Joseph J Campo, Carla Sanchez, Maria Yazdabankhsh, B Kim Lee Sim, Stephen L Hoffman, Peter Kremsner, Bertrand Lell, Benjamin Mordmüller, Carlota Dobaño, Gemma Moncunill\",\"doi\":\"10.1007/s00430-025-00847-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Continuous exposure to Plasmodium falciparum (Pf) has been associated with alterations in B cells. We investigated the effect of controlled human malaria infection (CHMI) on B cell phenotypes in individuals with different Pf immunity status: malaria-naïve, immunized with PfSPZ-CVac and semi-immune (lifelong-exposed) volunteers. Compared to naïve, semi-immune but not vaccinated individuals, had increased baseline frequencies of immature B cells (CD19<sup>+</sup>CD10<sup>+</sup>), active naive (IgD<sup>+</sup>CD27<sup>-</sup>CD21<sup>-</sup>) B cells, active atypical (IgD<sup>-</sup>CD27<sup>-</sup>CD21<sup>-</sup>) memory B cells (MBCs), active classical (IgD<sup>-</sup>CD27<sup>+</sup>CD21<sup>-</sup>) MBCs and CD1c<sup>+</sup>-B cells but lower frequencies of some IgG<sup>+</sup>-B cells. The frequencies of CD1c<sup>+</sup> active atypical MBCs correlated positively with anti-Pf antibodies and negatively with circulating eotaxin levels, while the opposite was observed for IgG<sup>+</sup> resting atypical MBCs. During early blood-stage infection (day 11 after CHMI), there was an expansion of resting classical (IgD<sup>-</sup>CD27<sup>+</sup>CD21<sup>+</sup>) MBCs in all three groups. Vaccination, compared to placebo, altered the effect of CHMI on B cells, showing a positive association with resting classical MBCs (β = 0.190, 95% CI 0.011-0.368) and active naïve-PD1<sup>+</sup> (β = 0.637, 95% CI 0.058 to 1.217) frequencies, and a negative one with CD1c<sup>+</sup> resting atypical MBCs (β = - 0.328, 95% CI - 0.621 to - 0.032). In addition, the sickle cell trait in semi-immune subjects altered the effect of CHMI on several B cells. In conclusion, lifelong but not vaccine exposure to malaria was associated with increased frequencies of multiple B cell subsets, with higher and lower percentages of CD1c and IgG expressing-cells, respectively. A single infection (CHMI) induces changes in B cell frequencies and is modulated by sickle cell trait and malaria-immunity status.Clinical Trials Registration NCT01624961, NCT02115516, and NCT02237586.</p>\",\"PeriodicalId\":18369,\"journal\":{\"name\":\"Medical Microbiology and Immunology\",\"volume\":\"214 1\",\"pages\":\"47\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-09-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476306/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Microbiology and Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00430-025-00847-x\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Microbiology and Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00430-025-00847-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Effect of controlled human Plasmodium falciparum infection on B cell subsets in individuals with different levels of malaria immunity.
Continuous exposure to Plasmodium falciparum (Pf) has been associated with alterations in B cells. We investigated the effect of controlled human malaria infection (CHMI) on B cell phenotypes in individuals with different Pf immunity status: malaria-naïve, immunized with PfSPZ-CVac and semi-immune (lifelong-exposed) volunteers. Compared to naïve, semi-immune but not vaccinated individuals, had increased baseline frequencies of immature B cells (CD19+CD10+), active naive (IgD+CD27-CD21-) B cells, active atypical (IgD-CD27-CD21-) memory B cells (MBCs), active classical (IgD-CD27+CD21-) MBCs and CD1c+-B cells but lower frequencies of some IgG+-B cells. The frequencies of CD1c+ active atypical MBCs correlated positively with anti-Pf antibodies and negatively with circulating eotaxin levels, while the opposite was observed for IgG+ resting atypical MBCs. During early blood-stage infection (day 11 after CHMI), there was an expansion of resting classical (IgD-CD27+CD21+) MBCs in all three groups. Vaccination, compared to placebo, altered the effect of CHMI on B cells, showing a positive association with resting classical MBCs (β = 0.190, 95% CI 0.011-0.368) and active naïve-PD1+ (β = 0.637, 95% CI 0.058 to 1.217) frequencies, and a negative one with CD1c+ resting atypical MBCs (β = - 0.328, 95% CI - 0.621 to - 0.032). In addition, the sickle cell trait in semi-immune subjects altered the effect of CHMI on several B cells. In conclusion, lifelong but not vaccine exposure to malaria was associated with increased frequencies of multiple B cell subsets, with higher and lower percentages of CD1c and IgG expressing-cells, respectively. A single infection (CHMI) induces changes in B cell frequencies and is modulated by sickle cell trait and malaria-immunity status.Clinical Trials Registration NCT01624961, NCT02115516, and NCT02237586.
期刊介绍:
Medical Microbiology and Immunology (MMIM) publishes key findings on all aspects of the interrelationship between infectious agents and the immune system of their hosts. The journal´s main focus is original research work on intrinsic, innate or adaptive immune responses to viral, bacterial, fungal and parasitic (protozoan and helminthic) infections and on the virulence of the respective infectious pathogens.
MMIM covers basic, translational as well as clinical research in infectious diseases and infectious disease immunology. Basic research using cell cultures, organoid, and animal models are welcome, provided that the models have a clinical correlate and address a relevant medical question.
The journal also considers manuscripts on the epidemiology of infectious diseases, including the emergence and epidemic spreading of pathogens and the development of resistance to anti-infective therapies, and on novel vaccines and other innovative measurements of prevention.
The following categories of manuscripts will not be considered for publication in MMIM:
submissions of preliminary work, of merely descriptive data sets without investigation of mechanisms or of limited global interest,
manuscripts on existing or novel anti-infective compounds, which focus on pharmaceutical or pharmacological aspects of the drugs,
manuscripts on existing or modified vaccines, unless they report on experimental or clinical efficacy studies or provide new immunological information on their mode of action,
manuscripts on the diagnostics of infectious diseases, unless they offer a novel concept to solve a pending diagnostic problem,
case reports or case series, unless they are embedded in a study that focuses on the anti-infectious immune response and/or on the virulence of a pathogen.